T-cell acute lymphoblastic leukemia (ALL) is a less common subtype of acute lymphoblastic leukemia. It happens more often in adults than in children.
T-cell ALL starts in immature cells that would normally develop into T cells, a type of white blood cell. T cells are part of your immune system and help your body fight disease.
In T-cell ALL, these immature cells do not develop into normal, working blood cells. Instead, they multiply out of control.
T-cell Acute Lymphoblastic Leukemia Care Tailored to You
You and your family are our top priority. At Fred Hutch Cancer Center, we offer comprehensive and compassionate care — personalized to you. You'll have access to the latest treatment options, clinical trials and supportive care services.
How T-cell ALL is Identified
Your care team will use your test results to learn more about your leukemia cells. Knowing whether you have T-cell ALL helps your care team understand your disease and plan your treatment.
Learn more about ALL testing and diagnosis.
How T-cell ALL is Treated
Treatment for T-cell ALL is different for each person. Most people with ALL start with chemotherapy.
Depending on your disease and how it responds to treatment, your care team may recommend other treatments, such as a blood and marrow transplant or treatment through a clinical trial.
Your care team will explain your options and recommend a treatment plan based on your disease and your needs.
Learn more about ALL treatment.